Alzheimer’s disease (AD) is the most common form of dementia. It is a progressive and degenerative disease that affects patient’s memory, thinking and ability to interact socially. It affects about 1 in 10 people over 65 years and almost 1 in 4 people over 85 years.
Research shows that the presence of amyloid plaques in the brain is the pathological hallmark of Alzheimer’s disease. The presence of these plaques results in the memory loss, behavioral changes and neuronal cell death associated with the AD. Their accumulation also leads to a gradual increase in inflammation and oxidative stress throughout the brain. Thus, AD patients find it challenging to even complete the necessary daily activities like speaking, recalling memories with the progression of the disease.